Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 513 to 562 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 513\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent segment polarity protein dishevelled homolog dvl-1 (dishevelled-1) (dsh homolog 1). [source:swissprot;acc:o14640]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.596\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.344\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06975\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 514\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent segment polarity protein dishevelled homolog dvl-2 (dishevelled-2) (dsh homolog 2). [source:swissprot;acc:o14641]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.613\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.382\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06963\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 515\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pescadillo homolog 1. [source:swissprot;acc:o00541]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 251.297\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 234.941\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06962\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 516\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent u6 snrna-associated sm-like protein lsm8. [source:swissprot;acc:o95777]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 228.255\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.422\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0695\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 517\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent metaxin 2. [source:swissprot;acc:o75431]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.537\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 234.793\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06949\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 518\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleostemin; putative nucleotide binding protein, estradiol-induced. [source:refseq;acc:nm\_014366]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 250.858\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 234.563\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06947\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 519\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent segment polarity protein dishevelled homolog dvl-3 (dishevelled-3) (dsh homolog 3). [source:swissprot;acc:q92997]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.702\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.582\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06902\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 520\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sqv-7-like protein (fragment). [source:sptrembl;acc:o95454]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 214.754\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.565\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06897\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 521\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent exosome complex exonuclease rrp41 (ec 3.1.13.-) (ribosomal rna processing protein 41) (p12a). [source:swissprot;acc:q9npd3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 215.237\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 230.07\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06891\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 522\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pleiotropic regulator 1 (prl1homolog, arabidopsis); pleiotropic regulator 1 (prl1, arabidopsis homolog). [source:refseq;acc:nm\_002669]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 222.893\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 208.523\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 523\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent exosome complex exonuclease rrp4 (ec 3.1.13.-) (ribosomal rna processing protein 4). [source:swissprot;acc:q13868]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 215.237\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 230.07\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 524\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent exosome complex exonuclease rrp40 (ec 3.1.13.-) (ribosomal rna processing protein 40) (p10) (cgi-102). [source:swissprot;acc:q9nqt5]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 525\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent exosome complex exonuclease rrp46 (ec 3.1.13.-) (ribosomal rna processing protein 46) (p12b) (chronic myelogenous leukemia tumor antigen 28). [source:swissprot;acc:q9nqt4]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 526\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nnp-1 protein (novel nuclear protein 1) (nucleolar protein nop52) (nop52) (d21s2056e). [source:swissprot;acc:p56182]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 250.538\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 234.401\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06884\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 527\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dead (asp-glu-ala-asp) box polypeptide 31 isoform 1; dead/dexh helicase ddx31. [source:refseq;acc:nm\_022779]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 248.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 232.579\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06871\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 528\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent yme1-like 1 isoform 3; atp-dependent metalloprotease ftsh1 homolog. [source:refseq;acc:nm\_014263]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 222.146\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 237.393\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06864\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 529\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atp-dependent rna helicase ddx18 (dead-box protein 18) (myc-regulated dead-box protein) (mrdb). [source:swissprot;acc:q9nvp1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 251.653\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 235.506\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06856\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 530\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent u6 snrna-associated sm-like protein lsm6 (sm protein f). [source:swissprot;acc:q9y4y8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 227.483\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.994\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06803\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 531\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nuclear matrix protein nmp200 related to splicing factor prp19. [source:refseq;acc:nm\_014502]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 223.356\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 209.149\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06793\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 532\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger-like protein 9. [source:refseq;acc:nm\_033414]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 250.942\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 235.004\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06782\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 533\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent membrane-associated transporter protein (aim-1 protein) (melanoma antigen aim1). [source:swissprot;acc:q9umx9]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 534\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein-like 1 (gtp-binding protein hsr1). [source:swissprot;acc:p36915]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 535\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dna-directed rna polymerases i, ii, and iii 17.1 kda polypeptide (ec 2.7.7.6) (rpb17) (rpb8) (rpabc3). [source:swissprot;acc:p52434]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 236.662\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 252.708\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0678\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 536\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lupus la protein (sjogren syndrome type b antigen) (ss-b) (la ribonucleoprotein) (la autoantigen). [source:swissprot;acc:p05455]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 242.531\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 227.136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06778\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 537\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent putative pre-mrna splicing factor rna helicase (deah box protein 15) (atp-dependent rna helicase #46). [source:swissprot;acc:o43143]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 229.803\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.301\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06736\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 538\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dna-directed rna polymerase ii 7.6 kda polypeptide (ec 2.7.7.6) (rpb10) (rpb7.6) (rpabc5). [source:swissprot;acc:p52436]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 237.627\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 253.604\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06724\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 539\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein cgi-27 (c21orf19-like protein). [source:swissprot;acc:q9y316]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 236.964\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 252.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06708\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 540\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent selenide,water dikinase 2 (ec 2.7.9.3) (selenophosphate synthetase 2) (selenium donor protein 2). [source:swissprot;acc:q99611]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 222.156\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 208.201\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06703\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 541\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent flavoprotein oxidoreductase mical2. [source:refseq;acc:nm\_014632]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 542\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent inositol polyphosphate-4-phosphatase, type ii, 105kd; inositol polyphosphate 4-phosphatase ii; 4-phosphatase ii. [source:refseq;acc:nm\_003866]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 543\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent selenide,water dikinase 1 (ec 2.7.9.3) (selenophosphate synthetase 1) (selenium donor protein 1). [source:swissprot;acc:p49903]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 544\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent inositol polyphosphate-4-phosphatase, type 1 isoform b; inositol polyphosphate-4-phosphatase, type i, 107kd; 4-phosphatase i; inositol polyphosphate-4-phosphatase i. [source:refseq;acc:nm\_001566]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 545\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 6 (eif-6) (b4 integrin interactor) (cab) (p27(bbp)) (b(2)gcn homolog). [source:swissprot;acc:p56537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 248.866\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 233.287\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06678\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 546\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent wiskott-aldrich syndrome protein (wasp). [source:swissprot;acc:p42768]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.222\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 194.262\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06671\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 547\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent proto-oncogene c-crk (p38) (adapter molecule crk). [source:swissprot;acc:p46108]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 207.26\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 194.346\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06645\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 548\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tyrosine-protein kinase abl2 (ec 2.7.1.112) (tyrosine kinase arg). [source:swissprot;acc:p42684]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 549\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 550\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tyrosine-protein kinase hck (ec 2.7.1.112) (p59-hck/p60-hck) (hemopoietic cell kinase). [source:swissprot;acc:p08631]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 551\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent grb2-related adaptor protein 2 (gads protein) (growth factor receptor binding protein) (grblg) (grf40 adaptor protein) (grf-40) (grb-2-like protein) (grb2l) (grbx) (p38) (hematopoietic cell-associated adaptor protein grpl) (adapter protein grid) (sh3-sh2-sh3 adaptor mona). [source:swissprot;acc:o75791]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.261\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 194.347\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 552\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent crk-like protein. [source:swissprot;acc:p46109]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 207.26\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 194.346\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 553\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent proto-oncogene tyrosine-protein kinase abl1 (ec 2.7.1.112) (p150) (c-abl). [source:swissprot;acc:p00519]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 554\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent proto-oncogene tyrosine-protein kinase fyn (ec 2.7.1.112) (p59-fyn) (syn) (slk). [source:swissprot;acc:p06241]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 555\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent proto-oncogene tyrosine-protein kinase fgr (ec 2.7.1.112) (p55-fgr) (c-fgr). [source:swissprot;acc:p09769]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 556\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ccaat displacement protein (cdp) (cut-like 1). [source:swissprot;acc:p39880]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 194.368\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06638\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 557\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent homeobox protein cux-2 (cut-like 2) (fragment). [source:swissprot;acc:o14529]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.272\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 194.371\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06637\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 558\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin activating enzyme e1-like protein. [source:refseq;acc:nm\_006395]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 135.087\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 144.041\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06628\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 559\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neural wiskott-aldrich syndrome protein (n-wasp). [source:swissprot;acc:o00401]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.309\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 194.452\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06612\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 560\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent son of sevenless protein homolog 1 (sos-1). [source:swissprot;acc:q07889]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 205.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 193.021\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06589\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 561\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent son of sevenless protein homolog 2 (sos-2). [source:swissprot;acc:q07890]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 205.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 193.183\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06578\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 562\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ptb domain adaptor protein ced-6; engulfment adapter protein. [source:refseq;acc:nm\_016315]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 220.744\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.121\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06577\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/